State
73,100 recalls have nationwide distribution and so reach New Mexico. 3,628 additional recalls listed New Mexico specifically in their distribution scope.
Of the 3,628 recalls naming New Mexico we have scored against our rubric, 747 (21%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 649 (18%) are Severe.
Which agencies issued them
These figures cover only the 3,628 recalls whose distribution notice names New Mexico specifically. The 73,100 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Land Rover is recalling certain 2022-2023 Range Rover vehicles because water may enter the rearview camera, blanking or distorting the image. 11,961 units are affected.
Chrysler is recalling certain 2024 Jeep Wagoneer, Grand Wagoneer, Grand Cherokee and Grand Cherokee L vehicles because incorrect camera module software may blank the rearview image.
Chrysler is recalling 2025 Ram 1500 trucks because incorrect headlight software may cause the lights to stop working, increasing crash risk.
Chrysler is recalling specific Mopar rearview camera modules because incorrect software may prevent the image from displaying, increasing crash risk.
Melii Baby silicone spoons for babies can break apart during use, creating a choking hazard. About 85,100 units sold through multiple retailers from April to August 2024 are affected; consumers should stop using them immediately.
Elongdi magnetic building stick sets sold on Amazon are recalled due to violation of federal toy magnet regulations. When swallowed, the high-powered magnets can attract each other and lodge in the digestive system, potentially causing serious internal injuries.
Acura is recalling certain 2021-2023 TLX vehicles because the fuel filler neck and fuel tank may have been improperly welded, which can result in a fuel leak.
Viatris Inc. is recalling 19,549 bottles of Levothyroxine Sodium 175 mcg tablets nationwide due to potency failures. Some tablets contain excessive active ingredient while others contain insufficient amounts.
Microline Surgical is recalling ReNew Microscissor Tip (Disposable) lot 00172110 due to a 2% failure rate where the heat shrink breaks off.
The BD Pyxis MedStation ES automated dispensing cabinet may dispense the wrong medication due to a software issue, potentially causing medication errors and inventory shortages.
A software issue in the BD Pyxis CII Safe ES automated dispensing cabinet may cause it to open the wrong medication pocket, risking incorrect medication removal or refills.
Mylan Institutional recalls 690 cartons of Levothyroxine Sodium 150 mcg tablets nationwide due to potency variation. Some units may be subpotent or superpotent.
Viatris Inc. is recalling Levothyroxine Sodium 200 mcg tablets nationwide due to potency failures—some tablets are superpotent while others are subpotent. Affected lots expire July 2025; patients should contact their healthcare provider.
Mylan Institutional is recalling 2,835 cartons of Levothyroxine Sodium 100 mcg tablets nationwide due to potency deviations—some tablets may be underdosed while others may be overdosed.
Viatris Inc is recalling Levothyroxine Sodium Tablets USP 75 mcg due to potency failures affecting approximately 63,077 bottles distributed nationwide in the US and Puerto Rico. Some tablets are superpotent while others are subpotent.
Mylan Institutional recalls 1,133 cartons of Levothyroxine Sodium Tablets (137 mcg) nationwide. Three lots contain subpotent and superpotent tablets.
Cardinal Health is recalling 940,203 Convertor Isolation Gowns because raw materials may prevent them from meeting AAMI Level 3 protection specifications.
Mercedes-Benz is recalling 2025 E 350, E 350 4MATIC, E 450 4MATIC, and E 450 4MATIC station wagon vehicles due to an improperly welded camber strut bracket on the rear axle carrier that may separate and cause loss of vehicle handling and control.
Viatris Inc is recalling 35,883 bottles of Levothyroxine Sodium Tablets (112 mcg) distributed nationwide due to potency failures. Some tablets contain too much active ingredient (superpotent) and others too little (subpotent). No illnesses have been reported.
Ascend Laboratories is recalling Dabigatran Etexilate 150mg capsules due to elevated N-nitroso-Dabigatran impurity from a manufacturing deviation. Affected lots were distributed nationwide; consult your physician before making changes to your medication.
Viatris Inc is recalling Levothyroxine Sodium Tablets USP, 137 mcg due to potency failures in some tablets being stronger or weaker than specified. The recall affects 118,324 bottles distributed nationwide in the United States and Puerto Rico.
Viatris Inc is recalling Levothyroxine Sodium Tablets USP 150 mcg nationwide due to potency failures. Affected lots containing both subpotent and superpotent tablets expire June 2025.
Viatris Inc recalls 43,765 bottles of Levothyroxine Sodium 88 mcg tablets nationwide due to potency failures where some tablets are stronger and others weaker than labeled.
Ascend Laboratories is recalling Dabigatran Etexilate 75 mg capsules nationwide due to manufacturing deviations. Three lots contain N-nitroso-Dabigatran impurity above recommended interim limits.
General Motors is recalling certain 2025 Chevrolet Silverado EV work trucks because the pedestrian alert sound system may not produce sound at sufficient volume. This increases the risk of pedestrians being unaware of an approaching vehicle.